Literature DB >> 10799439

Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis.

M E Heeley1, D A Woolf, A F Heeley.   

Abstract

AIM: To investigate whether analytical methods based on the colligative physical chemical properties of ions or solutes in sweat are less effective than the specific measurement of electrolytes in the diagnosis of cystic fibrosis (CF).
METHODS: A single sweat sample was collected (Macroduct) from each of 211 infants and children, of whom 57 had CF, for the measurement of sodium, chloride, osmolality, and conductivity.
RESULTS: The ranges within which CF and non-CF individual values overlapped (equivocal ranges), were wider for sodium and osmolality measurement than for chloride or conductivity. Neither of the latter two measurements provided a discriminatory advantage over the other. The utilisation of broadly based age related ranges for non-CF control subjects served to improve the discriminatory power of all four measurements to an extent that, in this cohort, both chloride and conductivity provided complete discrimination.
CONCLUSION: Sweat conductivity is as effective as chloride measurement in the laboratory diagnosis of CF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799439      PMCID: PMC1718326          DOI: 10.1136/adc.82.5.420

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

2.  Abnormal frequency of delta F508 mutation in neonatal transitory hypertrypsinaemia.

Authors:  D Laroche; G Travert
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

3.  Sweat sodium and chloride concentrations--essential criteria for the diagnosis of cystic fibrosis in adults.

Authors:  S K Hall; D E Stableforth; A Green
Journal:  Ann Clin Biochem       Date:  1990-07       Impact factor: 2.057

Review 4.  Cystic fibrosis.

Authors:  T J David
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

5.  Sweat testing for the diagnosis of cystic fibrosis: practical considerations.

Authors:  V A LeGrys
Journal:  J Pediatr       Date:  1996-12       Impact factor: 4.406

6.  A study of sweat sodium and chloride; criteria for the diagnosis of cystic fibrosis.

Authors:  A Green; P Dodds; C Pennock
Journal:  Ann Clin Biochem       Date:  1985-03       Impact factor: 2.057

7.  Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.

Authors:  M Wilschanski; J Zielenski; D Markiewicz; L C Tsui; M Corey; H Levison; P R Durie
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

8.  Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis.

Authors:  K B Hammond; N L Turcios; L E Gibson
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

9.  Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.

Authors:  P M Farrell; R E Koscik
Journal:  Pediatrics       Date:  1996-04       Impact factor: 7.124

10.  Improved sweat test method for the diagnosis of cystic fibrosis.

Authors:  E P Carter; A D Barrett; A F Heeley; J A Kuzemko
Journal:  Arch Dis Child       Date:  1984-10       Impact factor: 3.791

View more
  10 in total

1.  Changes in the index of sweat ion concentration with increasing sweat during passive heat stress in humans.

Authors:  A K M Shamsuddin; S Yanagimoto; T Kuwahara; Y Zhang; C Nomura; N Kondo
Journal:  Eur J Appl Physiol       Date:  2005-03-12       Impact factor: 3.078

2.  Clinical course of patients with major histocompatibility complex class II deficiency.

Authors:  M A Saleem; P D Arkwright; E G Davies; A J Cant; P A Veys
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

3.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

4.  Kawasaki disease complicated by renal artery stenosis.

Authors:  B J Foster; C Bernard; K N Drummond
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

5.  Nanoduct sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis.

Authors:  Marie-Claire Desax; Roland A Ammann; Jürg Hammer; Martin H Schoeni; Jürg Barben
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

6.  Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening.

Authors:  Annette Vernooij-van Langen; Edward Dompeling; Jan-Bart Yntema; Bert Arets; Harm Tiddens; Gerard Loeber; Jeannette Dankert-Roelse
Journal:  Eur J Pediatr       Date:  2015-02-13       Impact factor: 3.183

7.  Performance Evaluation of a New Coulometric Endpoint Method in Sweat Testing and Its Comparison With Classic Gibson&Cooke and Chloridometer Methods in Cystic Fibrosis.

Authors:  Yasemin Gokdemir; Pinar Vatansever; Bulent Karadag; Tuncay Seyrekel; Ozgur Baykan; Nilay Bas Ikızoglu; Refika Ersu; Fazilet Karakoc; Goncagul Haklar
Journal:  Front Pediatr       Date:  2018-05-22       Impact factor: 3.418

Review 8.  Processing Newborn Bloodspot Screening Results for CF.

Authors:  Jürg Barben; Jane Chudleigh
Journal:  Int J Neonatal Screen       Date:  2020-03-25

9.  Nanoduct sweat conductivity measurements in 2664 patients: relationship to age, arterial blood gas, serum electrolyte profiles and clinical diagnosis.

Authors:  Rabia Gonul Sezer; Gokhan Aydemir; Abdullah Baris Akcan; Cem Paketci; Abdulbaki Karaoglu; Secil Aydinoz; Abdulkadir Bozaykut
Journal:  J Clin Med Res       Date:  2013-01-11

10.  Self-powered smart patch for sweat conductivity monitoring.

Authors:  Laura Ortega; Anna Llorella; Juan Pablo Esquivel; Neus Sabaté
Journal:  Microsyst Nanoeng       Date:  2019-01-28       Impact factor: 7.127

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.